An interventional study of Acetabular cup in Osteoarthritis, Rheumatoid Arthritis and Arthritis, sponsored by DePuy Orthopaedics. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2014-07-29.
Sponsored by DePuy Orthopaedics · Not applicable, Interventional, and Treatment
This study is a clinical evaluation of survivorship of an acetabular cup system after total hip replacement using patient examinations and questionnaires.
The primary objective of this investigation is to evaluate survivorship at five years of the Pinnacle™ acetabular cup system in primary total hip arthroplasty.
3,554 studies on the registry are indexed under Arthritis; 317 are open to participants now.
This study's enrollment of 1,593 is above the median of 90 across 2,377 interventional studies indexed under Arthritis.
Browse Arthritis studies →DePuy Orthopaedics is the lead sponsor of 42 studies on the registry; 2 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 8 (100%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Acetabular cup replacement with total hip arthroplasty
Device: Acetabular cup
Acetabular cup replacement
Also known as: Pinnacle™ Cup
Survivorship
Time frame: 5 years
Harris Hip Score
Time frame: Pre-operative, 6 month and 1, 2, 3, 4, and 5 years.
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time frame: Pre-operative, 6 month and 1, 2, 3, 4 and 5 years.
Short Form-36 (SF-36)
Time frame: Pre-operative, 6 month and 1, 2, 3, 4 and 5 years.
This study is completed, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
DePuy Orthopaedics